The Online Investor

Slideshow Stock Splits

By The Online Investor Staff, updated Fri., Sep. 30, 4:16 PM

Slide #4. CohBar, Inc. (NASDAQ:CWBR) 1 for 30 Reverse Split

Announced: 9/22/2022
Stock Split: 1 for 30
Record Date: 9/23/2022
Pay Date: 9/23/2022
CWBR Optionable?: No

CohBar is a clinical stage biotechnology company utilizing the power of the mitochondria and the peptides encoded in its genome to develop potential breakthrough therapeutics targeting chronic and age-related diseases with limited to no treatment options. In addition, Co. has multiple preclinical programs, such as a program in acute respiratory distress syndrome as well as earlier stage discovery programs. Co.'s pipelines include: CB5138-3, which is for the treatment of idiopathic pulmonary fibrosis and other fibrotic diseases; CB4211, which is for the treatment of nonalcoholic steatohepatitis and obesity; and CB5064 Analogs, family of peptides that are agonists of the apelin receptor.
CWBR Detailed Information Page & Split History »

Company Name: 
CohBar Inc
Website: 
www.cohbar.com
Sector: 
Biotechnology
Number of ETFs Holding CWBR: 
2
Total Market Value Held by ETFs: 
$3.75M
Total Market Capitalization: 
$9.00M
% of Market Cap. Held by ETFs: 
41.69%

Open the CWBR Page at The Online Investor (in a new window) »

Quotes delayed 20 minutes

Email EnvelopeFree CWBR Email Alerts:
Get SEC Filing Alerts
Get Dividend Alerts

Strong Buy (4.00 out of 4)
92nd percentile
(ranked higher than approx. 92% of all stocks covered)
Based on Zacks ABR data;
powered by Xignite

Stock Splits Page | www.TheOnlineInvestor.com

Copyright © 1998 - 2022, All Rights Reserved
Nothing in The Online Investor is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and stock market videos powered by Market News Video. Quote data delayed at least 20 minutes; data powered by Ticker Technologies, and Mergent. Contact The Online Investor; Meet Our Editorial Staff.